key: cord-0816274-uyzjfot4
authors: Kado, Soichiro; Kamiya, Koji; Iwabuchi, Satoshi; Kajii, Eiji; Ohtsuki, Mamitaro
title: Unilateral lymphadenopathy associated with COVID‐19 vaccination
date: 2021-10-28
journal: Journal of Cutaneous Immunology and Allergy
DOI: 10.1002/cia2.12217
sha: 24f9f6c20fc27e4839141c8fbf4e266881e49b97
doc_id: 816274
cord_uid: uyzjfot4

During the ongoing coronavirus disease (COVID‐19) pandemic, COVID‐19 vaccination is rapidly progressing in many countries of the world. Given the rapid administration of COVID‐19 vaccines, it is speculated that dermatologists also have the opportunity to experience side effects of these vaccines. Here, we report a case of unilateral lymphadenopathy associated with COVID‐19 vaccination that presented to our outpatient department of dermatology with subcutaneous nodules.[Image: see text]

Dear Editor, During the ongoing coronavirus disease (COVID-19) pandemic, COVID-19 vaccination is rapidly progressing in many countries of the world. Dermatologists also have the opportunity to experience side effects of these vaccines. Here, we report a case of unilateral lymphadenopathy associated with COVID-19 vaccination that presented to our outpatient department of dermatology with subcutaneous nodules. Our patient denied to receive the second dose for fear of side effects. Among patients who presented with lymphadenopathy after the first dose, some patients presented with lymphadenopathy again after the second dose, while others did not. 8 Further case accumulation is needed because the next dose of vaccine should be discussed in these patients.

Approval of the research protocol: No human participant was involved in this study.

Informed Consent: The patient has provided informed consent for the publication of the images submitted with this article.

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination

FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1)

Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination

Neck and supraclavicular lymphadenopathy secondary to 9-valent human papillomavirus vaccination

Lymphadenopathy after the anti-COVID-19 vaccine: multiparametric ultrasound findings

Lymphadenopathy after BNT162b2 Covid-19 vaccine: preliminary ultrasound findings

Lymphadenopathy associated with the COVID-19 vaccine